ISPE GAMP 5 Guide - A Risk-Based Approach to Compliant GxP Computerized Systems 2022 PDF

Full title and description

ISPE GAMP® 5 Guide — A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition, 2022). This guidance document from the International Society for Pharmaceutical Engineering (ISPE) provides a pragmatic, risk-based framework for planning, implementing and assuring computerized systems used in GxP-regulated environments, emphasizing fit-for-purpose approaches, critical thinking by subject-matter experts, and proportionality in validation and assurance activities.

Abstract

The second edition of the GAMP 5 Guide (July 2022) updates the original GAMP® 5 principles to reflect modern software development approaches, expanded supplier and service-provider roles, increased use of automation and software tools, and contemporary data-integrity and computerized system assurance (CSA) considerations. It maintains a life-cycle approach and provides practical guidance, examples and appendices to support regulated companies, suppliers and regulators in achieving compliant, fit-for-purpose computerized systems.

General information

• Status: Published guidance (second edition — active ISPE good practice guidance).
• Publication date: July 2022.
• Publisher: ISPE (International Society for Pharmaceutical Engineering).
• ICS / categories: Pharmaceutical engineering; quality and compliance for computerized systems; GxP computerized system assurance and validation (life sciences guidance / good practice).
• Edition / version: 2nd Edition (2022).
• Number of pages: 404 pages (approx.).

Scope

The Guide covers the application of GAMP® 5 principles across the computerized system life cycle in GxP-regulated activities (manufacturing, quality, clinical, and related functions). It addresses risk-based classification and assurance strategies, supplier engagement and oversight, iterative and incremental development approaches, use of cloud services and other hosted solutions, data integrity expectations, and emerging topics such as AI/ML, open-source software and automation. The second edition explicitly links GAMP approaches with contemporary CSA thinking and provides expanded appendices with practical examples.

Key topics and requirements

• Risk-based lifecycle model for computerized systems (concept, development/configuration, testing/verification, installation, operation, retirement).
• System categorization and impact assessment to determine the appropriate level of assurance and validation effort.
• Supplier and service provider management, including leveraging supplier deliverables and documentation where appropriate.
• Principles for modern software development (iterative/incremental methods) and application of critical thinking rather than prescriptive checklists.
• Data integrity expectations, records management, and alignment with CSA approaches.
• Controls and considerations for cloud-hosted systems, automation tools, and emerging technologies (AI/ML, blockchain, open-source components).
• Examples, templates and appendices to support implementation across different system types and risk levels.

Typical use and users

The Guide is used by regulated pharmaceutical, biotech and medical device companies, contract manufacturers, contract research organisations, system suppliers, integrators, QA and compliance teams, validation engineers, IT and automation groups, and regulatory reviewers. It is intended as practical good-practice guidance to help teams determine proportionate, risk-based assurance strategies for computerized systems that impact product quality, patient safety and data integrity.

Related standards

GAMP 5 is complementary to regulatory and industry guidance such as EU GMP Annex 11 (computerized systems), FDA approaches to computerized system assurance and data integrity, PIC/S recommendations, and other ISPE GAMP good practice guides (e.g., Records & Data Integrity, Process Control Systems, eClinical). The Guide is intended to be used alongside applicable regulations and local regulatory expectations when defining compliant approaches.

Keywords

GAMP 5, ISPE, computerized system validation, computerized system assurance (CSA), risk-based approach, GxP, data integrity, supplier management, cloud, AI/ML, validation lifecycle, second edition (2022).

FAQ

Q: What is this standard?

A: It is an ISPE good-practice Guide (GAMP® 5, Second Edition) offering pragmatic, risk-based guidance for achieving compliant computerized systems in GxP-regulated environments.

Q: What does it cover?

A: The Guide covers a risk-based life-cycle approach to computerized systems, system categorization and impact assessment, supplier engagement, modern software development approaches, data integrity, and practical implementation guidance including appendices on emerging technologies and tools.

Q: Who typically uses it?

A: Users include validation and quality professionals, IT and automation teams, system suppliers and integrators, clinical and manufacturing stakeholders, and regulatory reviewers in the life sciences and healthcare sectors.

Q: Is it current or superseded?

A: This is the current second edition published in July 2022. As a living body of industry good practice, ISPE may issue additional good-practice guides and updates; users should confirm whether newer ISPE guidance or companion documents apply to their context.

Q: Is it part of a series?

A: Yes — GAMP® guidance is part of the ISPE GAMP Community of Practice suite of good-practice guides and resources, which includes focused guides (for example on records & data integrity, process control systems, eClinical systems, and enabling innovation) that complement the core GAMP 5 guidance.

Q: What are the key keywords?

A: Risk-based approach, GAMP 5, computerized system assurance/validation, GxP, data integrity, supplier management, cloud, AI/ML, lifecycle, ISPE (2022).